Among 500 students seen at a university health service for illnesses resembling infectious mononucleosis (IM), the Students with IM who showed a delayed emergence of the spectrum of EBVspecific antibodies characteristic of an acute infection were compared with control patients who had such antibodies at the time of their initial visit to the health service. They were found to have a briefer duration of illness (P > 0.05), lower leukocyte (P < 0.005), lymphocyte (P < 0.005), and atypical lymphocyte (P < 0.05) counts, and a less frequent occurrence of heterophil antibodies (P < 0.05).
Sprunt and Evans (24) described the clinical features of infectious mononucleosis (IM) in 1920, and shortly thereafter Downey and McKinlay (3) added a detailed description of the hematological findings for the disease. In 1937, the heterophil antibody (HA) test with differential absorption was shown to detect IM-specific HA, providing a third criterion for the diagnosis of IM (2, 19) . However, a specific etiological diagnosis did not become possible until three decades later, when Henle et al. (10) showed, in 1968, that the Epstein-Barr virus (EBV) caused this disease.
Initially, virus-specific serology was limited to immunoglobulin G (IgG) antibodies to viral capsid antigen (VCA) (9) . Under these circumstances, the diagnosis of IM relied on the emergence of IgG anti-VCA in retrospective studies and on the finding of a high titer of this antibody in clinical practice; since 85% of patients with IM already had peak levels of IgG anti-VCA at the time of diagnosis, a fourfold rise in titer was seldom observed. Subsequently, antibodies to other EBV-related antigens were discovered and t Present address: Division of Infectious Diseases, The
Children's Hospital of Philadelphia, Philadelphia, PA 19104. proved to be useful to the practitioner, allowing in most cases for the diagnosis of IM by assay of a single acute-phase serum (9, 11, 12, 21, 23) . Because of the overlap in IgG antibody titers to VCA that occurs between individuals with an acute primary EBV infection and those with infection in the distant past, it is now clear in retrospect that reliance on a high titer of IgG anti-VCA alone is not acceptable (12) .
During a study on EBV-specific serology. Initially, the sera were titrated for IgG antibodies to VCA and to the diffuse and restricted components of the early antigen complex (EA) by indirect immunofluorescence and for antibodies to the EBV-associated nuclear antigen (EBNA) by anticomplement immunofluorescence (9, 11, 21, 23 Eleven patients (group 2) with IM had no detectable IgG antibodies in their first serum to VCA, EA, or EBNA even when the tests were repeated and carefully scrutinized with sera retrieved from the freezer after the diagnosis of IM had been established. EBV-specific antibodies subsequently emerged in each of these 11 students (Table 3) . Those who were retested within several weeks had the expected pattern of a current primary infection, and one patient tested 6 months later had modest levels of IgG anti- (Fig. 1) . The mean total WBC, total lymphocyte, and atypical lymphocyte counts were significantly higher in the students with IM than in those with illnesses not due to EBV (P < 0.01, P < 0.005, and P < 0.005, respectively, by Student's t test); however, the total WBC and lymphocyte counts showed a considerable overlap. Using a lymphocyte count of _50% as diagnostic of IM gave a sensitivity of 62% and a specificity of 96%. Reliance on an atypical lymphocyte count _10% was slightly less sensitive (54%) but minimally more specific (98%). The requirement that both of the aforementioned hematological criteria be met for the diagnosis of IM led to the highest specificity (99%) but the lowest sensitivity (39%).
Comparison of patients in groups 1 and 2. The 11 IM patients with initially negative EBV serologies (group 2) were compared with 22 control patients, selected as described above from group 1, for duration of illness before the first visit, type of IM syndrome, presence of adenopathy and hepatosplenomegaly, and laboratory findings (Tables 4 and 5 ).
The WBC (P < 0.0005), lymphocyte (P < 0.005), and atypical lymphocyte (P < 0.05) counts were significantly higher in group 1 (Student t test). Although the patients in group 2 were sick for an average of 4.5 days before their first visit, compared with 8 days for those in group 1, and were more likely to have an angiose syndrome, these differences were not significant (chi-square test). However, group 2 patients were less likely to have a positive Monospot test (P < 0.05), a WBC count > 10,000/mm3 (P < 0.005), a lymphocyte count 2 50% (P < 0.005), or an atypical lymphocyte count 10% (P < 0.05). They met the hematological criteria for the diagnosis of IM significantly less often (P < 0.01) than did the patients in group 1.
DISCUSSION
IM has long been known as a frequent infection in young adults, particularly on college campuses (6-8, 22, 25) . Incidence rates for college students have been reported to vary from 1,000 to 4,000 per 100,000 annually. Studies at universities in the United States and Great Britain have shown, by periodically screening students for antibodies to EBV, that both overt and silent infections occur, the ratio being between 1:2 and 2:1 (6, 22, 25) .
Reliance on the presence of HA and the hematological findings is the general practice for college students (4, 12, 14) . Studies of patients with IM have shown that the majority have a positive test for HA and an absolute lymphocytosis, with 10% or more atypical cells (1, 4, 13, 15, 17, 18, 20) . Evans and colleagues (4) found 
